Healthcare ❯ Pharmaceuticals ❯ Drug Development

Regulatory Approval

Global Health Initiatives Lenacapavir Amtagvi FDA Submissions FDA Approval FDA Designations Market Strategy Conditional Marketing Authorization Market Entry ANVISA Marketing Authorization

EMA Panel Backs Conditional EU Approval for Rezurock in Chronic GvHD

The opinion now goes to the European Commission for a final EU decision.